NCT04168099View on ClinicalTrials.gov

Oral Gemifloxacin Versus Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis

PHASE3RecruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

December 1, 2028

Study Completion Date

December 30, 2028

Conditions

Spontaneous Bacterial Peritonitis

Interventions

DRUG

Cefotaxime

Cefotaxime IV

DRUG

Gemifloxacin

Gemifloxacin oral

Trial Locations (1)

Unknown

RECRUITING

Sherief Abd-Elsalam, Tanta

All Listed Sponsors

lead

Tanta University

OTHER